>_ QFI Terminal
TerminalStocks › SNYR

Synergy CHC Corp. (SNYR) Stock

Healthcare · Medical - Distribution · US
$0.09 -67.02%
Last updated Sep 20, 2026 13:07 UTC

SNYR Key Statistics

Market Cap$810,909.23
P/E (TTM)-0.07
P/S (TTM)0.03
P/B (TTM)-0.04
Revenue (TTM)$30.38M
EPS (TTM)$-1.27
Dividend Yield
ROE (TTM)83.11%
Net Margin-40.62%
Gross Margin66.72%
52W High$1.71
52W Low$0.07
Analyst ViewBuy
Price Target$5.00
Employees21
Volume64,981,505

About Synergy CHC Corp.

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.

CEO: Jack Ross. Company website

SNYR — Frequently Asked Questions

What is the SNYR stock price today?

Synergy CHC Corp. (SNYR) trades at $0.09, down 67.02% on the day, as of Sep 20, 2026 13:07 UTC.

What is Synergy CHC Corp.'s market cap?

Synergy CHC Corp. has a market capitalisation of $810,909.23, calculated from the live SNYR share price and shares outstanding.

What is the P/E ratio of SNYR?

SNYR has no meaningful price-to-earnings ratio: Synergy CHC Corp. lost $1.27 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Synergy CHC Corp. make?

Synergy CHC Corp. generated revenue of $30.38M over the trailing twelve months, which puts the stock at 0.03 times sales.

What is the 52-week range for SNYR?

SNYR has traded between $0.07 and $1.71 over the past 52 weeks, and the last price is 94.7% below that high.

Is Synergy CHC Corp. profitable?

No. Synergy CHC Corp. is loss-making, with a net margin of -40.62% over the trailing twelve months.

What is the analyst price target for SNYR?

Wall Street analysts rate SNYR Buy, with an average price target of $5.00, 5,424.9% above the current price.

What sector is Synergy CHC Corp. in?

Synergy CHC Corp. is classified under the Healthcare sector and the Medical - Distribution industry, and is domiciled in US .

Who is the CEO of Synergy CHC Corp.?

Jack Ross is the chief executive of Synergy CHC Corp., which employs 21 people.

Where can I track SNYR in real time?

QFI Terminal shows SNYR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See SNYR live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open SNYR in Terminal See plans

Medical - Distribution stocks

MCK McKesson Corporation COR Cencora, Inc. CAH Cardinal Health, Inc. HSIC Henry Schein, Inc. OMI Owens & Minor, Inc. RDGT Ridgetech Inc. WGRX Wellgistics Health, Inc. MEHA Functional Brands, Inc. Common Stock

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.